Effect of Estrogen Treatment and Vitamin D Status on Differing Bioavailabilities of Calcium Carbonate and Calcium Citrate

The authors hypothesized that estrogen treatment or vitamin D status may affect the bioavailability of two common calcium supplements differently. Using data derived from a recent trial in 25 postmenopausal women, the authors found that AAUC of serum calcium after subtraction of placebo was significantly higher after calcium citrate (median, 0.85; 25th to 75th percentile, 0.70 to 3.15) than after calcium carbonate (0.25; −0.58 to 1.00) in non‐estrogen‐treated patients. There was no difference in the bioavailability of calcium between the two calcium formulations in estrogen‐treated patients. Bioavailability was also significantly higher with the citrate salt for the subgroups with lower serum 25‐hydroxyvitamin D and higher serum 1,25‐dihydroxyvitamin D concentrations. In summary, bioavailability of calcium from the calcium carbonate product was more dependent on estrogen treatment and vitamin D status than that of calcium citrate. This may explain the variable results of reported calcium supplementation studies.

[1]  R. St Arnaud,et al.  1,25-dihydroxyvitamin D(3)-independent stimulatory effect of estrogen on the expression of ECaC1 in the kidney. , 2002, Journal of the American Society of Nephrology : JASN.

[2]  M. Favus,et al.  Evidence for Absorption of Ionic Calcium and Soluble Calcium Complexes by the Duodenum and Cecum in the Rat , 2001, American journal of therapeutics.

[3]  P. Lips,et al.  Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. , 2001, Endocrine reviews.

[4]  Cecilia A. Hale,et al.  Absorbability and Cost Effectiveness in Calcium Supplementation , 2001, Journal of the American College of Nutrition.

[5]  J. Poindexter,et al.  Pharmacokinetic and Pharmacodynamic Comparison of Two Calcium Supplements in Postmenopausal Women , 2000, Journal of clinical pharmacology.

[6]  E. Mola,et al.  Low Vitamin D Levels in Outpatient Postmenopausal Women from a Rheumatology Clinic in Madrid, Spain: Their Relationship with Bone Mineral Density , 2000, Osteoporosis International.

[7]  C. Weaver,et al.  The new dietary reference intakes for calcium: implications for osteoporosis. , 1999, Journal of the American College of Nutrition.

[8]  J. C. Netelenbos,et al.  Estrogen Regulation of Intestinal Calcium Absorption in the Intact and Ovariectomized Adult Rat , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  R. Heaney,et al.  Absorption of Calcium as the Carbonate and Citrate Salts, with Some Observations on Method , 1999, Osteoporosis International.

[10]  B. L. Riggs,et al.  A Unitary Model for Involutional Osteoporosis: Estrogen Deficiency Causes Both Type I and Type II Osteoporosis in Postmenopausal Women and Contributes to Bone Loss in Aging Men , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  R. Heaney,et al.  Calcium absorptive effects of vitamin D and its major metabolites. , 1997, The Journal of clinical endocrinology and metabolism.

[12]  J. Manson,et al.  Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. , 1996, The New England journal of medicine.

[13]  J. Zerwekh,et al.  Disruption of Cholesterol 7α-Hydroxylase Gene in Mice , 1996, The Journal of Biological Chemistry.

[14]  D. Russell,et al.  Disruption of cholesterol 7alpha-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation. , 1996, The Journal of biological chemistry.

[15]  C. Fullmer,et al.  Vitamin D and intestinal calcium transport: facts, speculations and hypotheses. , 1995, The Journal of nutrition.

[16]  J. Daugirdas,et al.  Intracellular acidification associated with changes in free cytosolic calcium. Evidence for Ca2+/H+ exchange via a plasma membrane Ca(2+)-ATPase in vascular smooth muscle cells. , 1995, The Journal of clinical investigation.

[17]  M. Barger-Lux An investigation of sources of variation in calcium absorption efficiency [published erratum appears in J Clin Endocrinol Metab 1995 Jul;80(7):2068] , 1995 .

[18]  H. DeLuca,et al.  An investigation of sources of variation in calcium absorption efficiency. , 1995, The Journal of clinical endocrinology and metabolism.

[19]  Y. Seino,et al.  1,25-Dihydroxyvitamin D radioreceptor assay using bovine mammary gland receptor and non-high performance liquid chromatographie purification , 1994 .

[20]  Y. Seino,et al.  1,25-Dihydroxyvitamin D radioreceptor assay using bovine mammary gland receptor and non-high performance liquid chromatographic purification. , 1994, Clinica chimica acta; international journal of clinical chemistry.

[21]  Rajiv Ranjan Kumar,et al.  Vitamin D and adaptation to dietary calcium and phosphate deficiencies increase intestinal plasma membrane calcium pump gene expression. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Civitelli,et al.  Estrogen preserves a normal intestinal responsiveness to 1,25-dihydroxyvitamin D3 in oophorectomized women. , 1990, The Journal of clinical endocrinology and metabolism.

[23]  B. Finlayson,et al.  A model system for assessing physicochemical factors affecting calcium absorbability from the intestinal tract , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  R. Recker Calcium absorption and achlorhydria. , 2006, The New England journal of medicine.

[25]  R. Horst,et al.  A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies. , 1984, The Journal of clinical endocrinology and metabolism.

[26]  J. Zerwekh,et al.  Long term 25-hydroxyvitamin D3 therapy in postmenopausal osteoporosis: demonstration of responsive and nonresponsive subgroups. , 1983, The Journal of clinical endocrinology and metabolism.

[27]  R. Recker,et al.  Menopausal changes in calcium balance performance. , 1978, The Journal of laboratory and clinical medicine.